159 related articles for article (PubMed ID: 24938357)
1. 1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.
Rosli SN; Shintani T; Toratani S; Usui E; Okamoto T
In Vitro Cell Dev Biol Anim; 2014 Oct; 50(9):802-6. PubMed ID: 24938357
[TBL] [Abstract][Full Text] [Related]
2. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
3. 1α,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-κB pathway.
Rosli SN; Shintani T; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2013 Jul; 136():98-101. PubMed ID: 23104116
[TBL] [Abstract][Full Text] [Related]
4. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1).
Higaki M; Shintani T; Hamada A; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):222-233. PubMed ID: 32185608
[TBL] [Abstract][Full Text] [Related]
5. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D
Shintani T; Higaki M; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38713345
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis.
Begum S; Zhang Y; Shintani T; Toratani S; Sato JD; Okamoto T
Oncol Rep; 2007 Mar; 17(3):591-6. PubMed ID: 17273738
[TBL] [Abstract][Full Text] [Related]
7. Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells.
Shintani T; Higaki M; Okamoto T
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072393
[TBL] [Abstract][Full Text] [Related]
8. 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
Sundaram K; Sambandam Y; Tsuruga E; Wagner CL; Reddy SV
Horm Cancer; 2014 Apr; 5(2):90-7. PubMed ID: 24497297
[TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas.
Shintani T; Rosli SNZ; Takatsu F; Choon YF; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2016 Nov; 164():79-84. PubMed ID: 26444325
[TBL] [Abstract][Full Text] [Related]
10. Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.
Oak ASW; Bocheva G; Kim TK; Brożyna AA; Janjetovic Z; Athar M; Tuckey RC; Slominski AT
Anticancer Res; 2020 May; 40(5):2467-2474. PubMed ID: 32366390
[TBL] [Abstract][Full Text] [Related]
11. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
13. Expression of FGF-2/FGFR-1 in normal mucosa, salivary gland, preneoplastic, and neoplastic lesions of the oral cavity.
Mariz BALA; Soares CD; Morais TML; Fonseca FP; de Carvalho MGF; Jorge J
J Oral Pathol Med; 2018 Oct; 47(9):816-822. PubMed ID: 30080932
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
Akutsu N; Bastien Y; Lin R; Mader S; White JH
Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771
[TBL] [Abstract][Full Text] [Related]
15. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors.
Wu DQ; Kan MK; Sato GH; Okamoto T; Sato JD
J Biol Chem; 1991 Sep; 266(25):16778-85. PubMed ID: 1885605
[TBL] [Abstract][Full Text] [Related]
16. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing.
Tassi E; McDonnell K; Gibby KA; Tilan JU; Kim SE; Kodack DP; Schmidt MO; Sharif GM; Wilcox CS; Welch WJ; Gallicano GI; Johnson MD; Riegel AT; Wellstein A
Am J Pathol; 2011 Nov; 179(5):2220-32. PubMed ID: 21945411
[TBL] [Abstract][Full Text] [Related]
17. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
18. TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.
Bunai K; Okubo H; Hano K; Inoue K; Kito Y; Saigo C; Shibata T; Takeuchi T
J Cell Mol Med; 2018 Feb; 22(2):1026-1033. PubMed ID: 29164763
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
20. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
